TrialBMC cancer2015

A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies.

Adam Platt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.